Skip to main content

Table 3 Life prolonging treatments and diagnostic tests during the last week of life

From: End-of-life care of patients with idiopathic pulmonary fibrosis

  Place of death  
Tertiary hospital Community hospital Home, nursing home or hospice Total
Number of patients 26 21 12 59
Life prolonging treatments (last 7 days)
 NIV 13 (50 %) 4 (19 %)* 0 17 (29 %)
 Parenteral fluids 16 (62 %) 11 (52 %) 2 (16 %) 29 (49 %)
 Antibiotics 24 (92 %) 13 (62 %)* 2 (16 %) 39 (66 %)
Diagnostic tests (last 24 h)
 X-rays 8 (31 %) 1 (5 %)* 0 9 (15 %)
 Laboratory tests 18 (69 %) 7 (33 %)* 0 25 (42 %)
  1. NIV non-invasive ventilation
  2. * p < 0.05 for tertiary vs. community hospital